Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration Status February 2020

被引：6
作者：
German Society of Ophthalmology , German Retina Society , Professional Association of German Ophthalmologists
机构：
[1] Deutsch Ophthalmol Gesell, Platenstr 1, D-80336 Munich, Germany
[2] Retinolog Gesell eV, German Retina Soc, Freiburg, Germany
[3] Berufsverband Augenarzte Deutschlands eV, Profess Assoc German Ophthalmologists, Dusseldorf, Germany
来源：
OPHTHALMOLOGE | 2021年 / 118卷 / SUPPL 1期
关键词：
ENDOTHELIAL GROWTH-FACTOR; RANIBIZUMAB TREATMENT; CLINICAL BURDEN; VISUAL-ACUITY; PLAN REGIMEN; OUTCOMES; THERAPY; EFFICACY; VERTEPORFIN; BEVACIZUMAB;
D O I：
10.1007/s00347-020-01188-1
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：31 / 39
页数：9
相关论文
共 54 条
[1]   ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Treat-and-Extend Protocol Over 2 Years [J].
Abedi, Farshad ;
Wickremasinghe, Sanjeewa ;
Islam, Amirul F. M. ;
Inglis, Kellie M. ;
Guymer, Robyn H. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (08) :1531-1538
[2]  
[Anonymous], 2011, OPHTHALMOLOGE, V1, P86
[3]  
[Anonymous], 2017, OPHTHALMOLOGE, V114, P220
[4]  
[Anonymous], 2015, OPHTHALMOLOGE, V112, P237
[5]  
[Anonymous], 2013, KLIN MONBL AUGENHEIL, V230, P170
[6]  
[Anonymous], 2011, KLIN MONBL AUGENHEIL, V228, P138
[7]  
[Anonymous], 2013, OPHTHALMOLOGE, V110, P405
[8]  
[Anonymous], 2009, KLIN MONBL AUGENHEIL, V226, P388
[9]  
[Anonymous], 2012, OPHTHALMOLOGE, V109, P405
[10]  
[Anonymous], 2017, KLIN MONATSBL AUGENH, V234, P650
123456